Yusuke Hatakawa
Sendai, 9808578, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Characterization of ene reaction products of Cookson-type fluorescent reagents and their application for recognizing amyloid β aggregation.
Journal: Analytical sciences : the international journal of the Japan Society for Analytical Chemistry
Published: April 01, 2025
Delivery of JAL-TA9 to the brain by nasal application
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Published: November 04, 2024
Efficient nose-to-brain delivery of nine residues peptide (JAL-TA9) exhibiting hydrolytic activity against amyloid-β.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: October 17, 2024
Tyrosine modifications of insulin-degrading enzyme enable favorable control of substrate specificity for both Alzheimer's disease and type-2 diabetes mellitus.
Journal: Bioorganic chemistry
Published: June 21, 2024
Oxoammonium salts exert antiviral effects against coronavirus via denaturation of their spike proteins.
Journal: Scientific reports
Published: April 04, 2024
SKGQA, a Peptide Derived from the ANA/BTG3 Protein, Cleaves Amyloid-β with Proteolytic Activity.
Journal: Biomolecules
Published: March 14, 2024
Lipid peroxidation-derived modification and its effect on the activity of glutathione peroxidase 1.
Journal: Free radical biology & medicine
Published: July 05, 2023
Comparative studies for amyloid beta degradation: "Neprilysin vs insulysin", "monomeric vs aggregate", and "whole Aβ40 vs its peptide fragments".
Journal: Biochemistry and biophysics reports
Published: March 20, 2022
Amyloid beta cleavage by ANA-TA9, a synthetic peptide from the ANA/BTG3 Box A region.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: August 19, 2020
Last Updated: 09/26/2026